Vulnerability · CVE-2026-22460
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in wpWax FormGent formgent allows Path Traversal.This issue affects FormGe…
Published Mar 5, 2026 · catalog updated Jun 17, 2026 · the affected product
Check if you run it
No confirmed exploitation is on record for CVE-2026-22460. EPSS is 0.40%. Act only if a listed version of the affected product is installed.
Gaps on this record
- No plain product name is stored. The page cannot tell you which product to check.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- High8.6
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.40%
- Remediation
- Version ranges on file
- Affected products
- stated named in the record
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in wpWax FormGent formgent allows Path Traversal.This issue affects FormGent: from n/a through <= 1.7.0.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- stated named in the record<= 1.7.0
How to fix CVE-2026-22460
Recommended remediation
Affected version ranges suggest a fixed boundary. Verify against the vendor advisory for your release.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2026-22460. EPSS is 0.40%. Act only if a listed version of the affected product is installed.
Which versions are affected?
Compare what you have installed with named in the record <= 1.7.0. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-22: Path Traversal. EPSS 0.40%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Mar 5, 2026 · NIST NVD
Detected
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in wpWax FormGent formgent allows Path Traversal.This issue affects FormGent: from n/a through <= 1.7.0.
Jun 17, 2026 · NIST NVD
Updated
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in wpWax FormGent formgent allows Path Traversal.This issue affects FormGent: from n/a through <= 1.7.0.
Sources
- CVE.orgVulnerability recordCVE-2026-22460
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2026-22460
30-day exploitation probability 0.4%
first.org - NIST NVDVulnerability recordCVE-2026-22460
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in wpWax FormGent formgent allows Path Traversal.This issue affects FormGent: from n/a through <= 1.7.0.
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.